Navigation Links
FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
Date:11/20/2008

ent.com/prnews?Page=Quote&Ticker=LGND'> LGND). It was developed by GlaxoSmithKline.

The compound is also being studied for thrombocytopenia associated with chronic hepatitis C virus, chronic liver disease and oncology-related thrombocytopenia.

Important Safety Information

BOXED WARNING

PROMACTA may cause hepatotoxicity. Patients receiving therapy with PROMACTA must have regular monitoring of serum liver tests (see Laboratory Monitoring below). Discontinue PROMACTA if ALT levels increase to > / = 3X upper limit of normal (ULN) and are: progressive; or persistent for > / = 4 weeks, or; accompanied by increased direct bilirubin; or accompanied by clinical symptoms of liver injury or evidence for hepatic decompensation. Reinitiating treatment with PROMACTA is not recommended and should be considered only with close medical supervision and under exceptional circumstances where the potential benefit outweighs the risk.

Because of the risk for hepatotoxicity and other risks, PROMACTA is available only through a restricted distribution program called PROMACTA Cares. Under the PROMACTA CARES Program, only prescribers, pharmacies, and patients registered with the program are able to prescribe, dispense, and receive PROMACTA. To enroll in the PROMACTA CARES Program, call 1-877-9-PROMACTA.

Warnings and Precautions:

Additional safety information regarding Risk of Hepatotoxicity: Reinitiating treatment with PROMACTA is not recommended. If the potential benefit for reinitiating PROMACTA treatment is considered to outweigh the risk for hepatotoxicity, then cautiously reintroduce PROMACTA and measure serum liver tests weekly during the dose adjustment phase. If liver test abnormalities p
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire/--PraxisElectronicMedicalRecordsreceivedfir...ans,(AAFP)FamilyPracticeManagement(FPM)2009EHRUser...hmaintenance,anddiseasemanagement,allcriticalforne...ctorsindicatingtheirEMRhadapositiveeffectindetermi...nthecountryinprovidingexcellenttrainingandsupport....
(Date:11/25/2009)...e-FirstCall/--ERT(Nasdaq: ERES ),announcedtodaytha...andKeithSchneck,theCompany,sExecutiveVicePresident...ffrayHealthCareConferenceat1:30PMESTonDecember1,20...yaccessthepresentationbyvisitingtheCompany,scorpor...beaccessedat http://www.corporate-ir.net/ireye/con...
(Date:11/25/2009)...wire-USNewswire/--RemediumTechnologiesInc.,acompan...eeding,wonfirstprizeand$10,000intheMostPromisingSe...,companyofficialsannouncetoday. ,, Selectedfrom...mpitchedtheirinventionattheGSCSecuritySummitconfer...m( www.remediumtechnologies.com )isdevelopingahigh...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3USC Keck School of Medicines Dr Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL 2 Molecule Therapeutic 4693 1USC Keck School of Medicines Dr Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL 2 Molecule Therapeutic 4693 2USC Keck School of Medicines Dr Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL 2 Molecule Therapeutic 4693 3USC Keck School of Medicines Dr Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL 2 Molecule Therapeutic 4693 4Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 1Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 2Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 3Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 4Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 5Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 6Mini Strokes May Cause Vision Loss 50874 1Mini Strokes May Cause Vision Loss 50874 2Mini Strokes May Cause Vision Loss 50874 3
... Tolerability, PLYMOUTH MEETING, Pa., Aug. 8 Gen...interim data from the first,Phase 1 clinical study...obesity. Anthony DelConte, M.D., Vice President, C...squemine: A Novel Aminosterol for the,Treatment of...the IBC 12th,Annual World Congress on Drug Discove...
...er,surgery to remove the prostate (radical prostat... damage that theoretically should heal over time.,...s to recover enough for a,man to have an erection ...other damage may have occurred, according to an ar...ate Disease. The Harvard Medical School bulletin ...
Other Medicine Technology:Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference 2Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference 3Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference 4'Use it or Lose it': A New Theory About Preserving Erectile Function After Prostate Surgery 2
(Date:11/26/2009).../--Withcoldandfluseasonuponus,it,smoreimportanttha...ctionsandavoidillness. ,, "Weneedtobeproactiven...gillnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(c...ectioncontrolandoccupationalhealthatHospitalforSpe...ialSurgeryhasoneofthelowestinfectionratesofanyhosp...
(Date:11/26/2009)...vy can lead to strains or worse , , THUR...hing wrong with stuffing your turkey full to burst...ith your suitcase as you pack for holiday trips. ,...n U.S. hospital emergency rooms, doctors, offices,...related injuries, such as muscle strains, pulls an...
(Date:11/26/2009)...h Triangle Dental (RTDental), a leading dental gro...nced the expansion of its services to include LUMI...cmillan. , Durham, NC ...announce that Dr. Doug Macmillan, an experienced ...al advanced training seminar. RTDental’s ab...
(Date:11/25/2009)...ewswire/--TheBartleHallConventionCenterwilltempora...0,whenKansasCityhoststhelatestinaseriesofmassivefr...eventhasthepotentialtobethebiggestoneyet,becauseit...ekdaysinsteadofoveraweekend,"SheriWood,executivedi...ftheNationalAssociationofFreeClinics(NAFC). ,, ...
(Date:11/25/2009)...RNewswire/--Thanksgivingmealswillbedeliveredtoappr...hareathankstoFaithInAction/VolunteerActionforAging...onofSCANHealthPlan.Formorethan17yearstheseorganiza...ThanksgivingmealstoseniorsinneedinLongBeach,Lakewo...ngcities. ,, "Ourwarmholidaymealsaredeliveredto...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...football legend George Best has condemned the rela...ing it reflected a 'society falling apart'.// Th...sday, consigning the traditional 23:00 closing tim...or Roger Williams joined opponents who expressed f...
...ng, loads of anti-depressant medication and lifest...dolphin city to enjoy a splendid ride with a dolph...f treatment supports the theory of biophilia that ...n were chosen for the study and were randomized in...
...tion (CBI) of India on Monday conducted raids in v...ss the four Indian cities Delhi, Bangalore, Trivan...ave collected important information in connection ...nistry of Health and various Pharmaceutical compan...
... mothers face health risks, say researchers. Re...ensland's School of Population Health// tracked al...ood as part of one of the world's longest health s...age. Alati said they found teenage children ...
...arded as something, only capable of giving rise to...soon change.// Thanks to the fervent efforts of st...UCSF who have created the first-ever bacterial pho...s is what prompted these young minds to produce ba...
...on (WHO) said today that even though preventive me...experience and avoiding multiple sexual// partners... of AIDS cases across the globe is on the rise. ...reatens to swamp the world. These findings are pub...
Other Medicine News:Health News:Drinking Laws 'Fuel Disease' In UK: Expert 2Health News:Swimming With Dolphins Can Help Ease Depression 2Health News:Bacterial Photographs Created By Student Scientists! 2Health News:AIDS Numbers Continue To Rise : WHO 2
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: